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ABSTRACT 
Induction of angiogenesis within the artificial bone graft after implantation is of paramount 
importance in the field of bone tissue engineering. For this purpose, here, we are developing 
nickel ion doped nHAp which improves angiogenesis. nHAp doped with varying 
concentrations of nickel were prepared using wet chemical precipitation method using 
cationic surfactant (CTAB) as a template and the extent of doping was studied using EDAX. 
The prepared particles with ferret diameter of 15-17 nm (TEM analysis), showed almost 
similar surface area for all samples (using BET analysis) but there was an increase in surface 
charge observed as the doping increases (ZETA potential). Crystalline nature of doped 
hydroxyapatite particles were studied using XRD and FTIR. Detailed analysis relevant to the 
bone cells (Mg-63) proliferation and differentiation showed that doping of nickel to 
hydroxyapatite supports cell growth and proliferation (MTT, live dead assay and cell cycle 
analysis) and also differentiation of these cells which were analysed using in vitro Runx2 
expression and bone nodule formation by SEM study. VEGF expression by ELISA and HIF-
1α expression studies revealed that doping of nickel greatly supports angiogenesis. This 
confirms that nickel ion doped hydroxyapatite improves angiogenesis along with 
osteogenesis pinpointing its potential in bone tissue engineering application. 
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1.1. Biology of bone: 
1.1.2. Bone structure: 
There are generally two types of bone found in human body: trabecular and cortical bone. 
Cortical bones make up to 80 % of the total skeleton and are hard and compact but not much 
porous (flat bones and outer part of long bones). These bones have mineralised compartment 
and provides mechanical strength. On the other hand, trabecular bones (cancelous or spongy 
bones) make up to 20 % of the total skeleton and are highly porous arranged in a honeycomb-
like rods of various sizes called trabeculae. These cancelous bones are fully vascularized and 
help in the metabolic functions[1]. 
1.1.3. Bone cells: 
a) Osteoblasts – These are bone forming cells which initially form non-mineralized 
osteoids and later differentiate into osteocytes (mature osteoblasts) that gets 
embedded in the bone matrix. Osteoblasts are generally found in the cancelous bones 
where the metabolic rate is higher[2]. 
b) Osteoclasts – These multinucleated cells helps in bone resorption by degrading the 
organic component and dissolving the mineral component of the bone matrix when 
needed[2]. 
c) Osteocytes – These are the terminally differentiated cells which play a role in the 
normal metabolism of bone by transducing signals from mechanical stress, secreting 
necessary enzymes, controlling bone mineral content and release of calcium ions into 
the blood[2]. 
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1.1.4. Bone formation and remodelling: 
The formation of new bone is initiated with the process called cellular condensation in which 
the mesenchymal cells migrate from different parts and proliferate. Differentiation of the 
mesenchymal stem cells into pre-osteoblasts and osteoblasts occurs via one of the two 
mechanisms: endochondral ossification and intramembranous ossification. In endochondral 
ossification, the cartilage plate is first formed which gets replaced by the bone later, and 
mostly bone formation is through this process. In intramembranous ossification, 
mesenchymal stem cells directly differentiate into pre-osteoblasts and osteoblasts, and this 
mechanism occurs primarily in flat bones of the skull, scapula and mandible[3]. 
Bone is a connective tissue which undergoes continuous remodelling to maintain structural 
integrity. Remodelling of bone consists of two steps: bone resorption followed by new bone 
formation. During bone resorption, osteoclasts attach to the old and damaged bone surface 
and initiates the degradation of bone matrix by releasing factors. Osteoblasts then fill up the 
resorption area and helps in bone mineralization and formation of the new bone matrix. In a 
healthy bone, this process of resorption and formation in remodelling is very well co-
ordinated and balanced[4]. 
1.2.  Need for bone tissue engineering: 
Many bone related diseases like osteoporosis and osteoarthritis, genetic disorders like 
osteogenesis imperfecta and bone fractures need treatments which help in regeneration of 
bones. As the rate of bone defects and diseases increases, the need for bone substitutes also 
increases in the field of the orthopaedic health sector. One of the major concern is the proper 
integration of the bone substitutes with its natural counterpart. Conventional methods of 
treatment include the use of autografts and allografts that can integrate with the existing 
bones perfectly. But they come with limitations such as scarcity of donors, immunorejection, 
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donor site morbidity, severe pain and risk of infections and high chances of transmission of 
diseases (in case of allografts)[5]. These limitations gave way for the artificial prostheses for 
bone fractures (one of the major application of artificial prostheses is the use in hip bone 
fracture) but then the wearing of the implant material at times leads to the death of the bone 
cells at the site of fracture and also there won’t be any bonding between the chemically inert 
prostheses and the biological tissue. These limitations opened the door for the field of bone 
tissue engineering which uses a wide range of polymeric and ceramic scaffolds that fits 
perfectly into the bone defects and helps in osteointegration[6]. 
1.3.  Bone tissue engineering – current trends: 
The focus of bone tissue engineering field is on creating bone constructs that are capable of 
improving the osteogenesis in the site of the bone defect. Bone constructs are implanted by 
seeding the cells with osteogenic potential into the biodegradable scaffolds in vitro and 
directly transplanting in vivo to assess their potential in the formation of bone. Another kind 
of bone construct is that after cell seeding into the scaffolds, they were cultured in vitro to 
form mature bone-like grafts which are then implanted. The structural properties of the 
scaffold have a great influence on the cell growth and proliferation. Bone tissue scaffolds 
after implantation should have a macrostructure mimicking the physiological function of the 
matrix to maintain the cell’s natural phenotype. Porosity and interconnectivity of the scaffold 
(70-80 %) is also necessary for promoting tissue ingrowth and vascularization from 
surrounding tissues and also for the removal of the metabolic waste that has penetrated the 
scaffold from the surrounding cells. Most importantly scaffold should be bio-compatible and 
bio-degradable[7]. 
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1.4.  Biomaterials for bone tissue engineering: 
For a successful implantation, the scaffold should be highly biocompatible. The selected 
scaffold material should also degrade and resorb at a controllable rate at the same time as the 
specific tissue cells seeded into the construct attach, spread and increase in quantity as well as 
quality[8]. The design and fabrication of scaffolds in tissue engineering are driven by two 
main categories: polymers and ceramics. 
1.4.1. Polymeric biomaterials: 
Because of ease of design modification and surface modification, a variety of polymers have 
been used to fabricate scaffold. Generally two categories of polymers are found: 
biodegradable and non-biodegradable polymers. Biodegradable polymers are generally used 
for making scaffolds, and they have good mechanical properties and degrade at a controllable 
rate. Poly lactic acid (PLA), poly glycolic acid (PGA), collagen and co-poly L-lactide 
(CPLA) are some of the examples of biodegradable polymers. One of the important 
limitations of biodegradable polymers is that endothelial cells cannot adhere to these 
materials[9]. This gave opportunity for ceramic biomaterial for the application as scaffolds 
for bone tissue engineering.   
1.4.2. Ceramic biomaterials:  
Ceramic biomaterials based scaffolds are composed of metallic and non-metallic elements 
and inorganic ceramic materials. They have good mechanical behaviour such as hardness. 
However they are very brittle, requiring less energy to fracture. They can be bioinert, 
bioactive or bioresorbable. They do not bond with the bone, instead tissue ingrowth into 
ceramic pores happens. Bioactive ceramics is generally used for bone tissue engineering 
application and evoke biological response at bone tissue implant surface by exchange of ions 
to form a bond between the host tissue and the biomaterial. They can also be used as coating 
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on other non-bioactive materials such as metals to induce a strong biological fixation between 
the host tissue and implant material[10].  
1.4.3. Hydroxyapatite: 
Hydroxyapatite, with the chemical formulae Ca10(PO4)6(OH)2 is one such bioactive ceramic 
which is chemically similar to the inorganic phase of natural bone and used widely in bone 
tissue engineering. It is chemically stable at acidity levels less than 4.3 (which is the pH of 
blood)[11]. Much like calcium phosphates, HAp also has osteoconductive and osteoinductive 
properties. Bioactivity is related to a modification of the surface of the HAp material. Its 
bioactivity has been seen to be affected by structural crystallinity. The theortical mole ratio of 
Ca and P in HAp is 1.67. However, this is not the value observed in the organism because 
small amounts of carbon, nitrogen, iron and other elements are also incorporated. In the 
hexagonal systems, the hydroxyl ions (OH-) are located at the centre of Ca+2 triangles along 
the c-axes of the hexagonal unit cell. The OH- ions are aligned in columns parallel to the c-
axis along with Ca+2 and (PO4
-3) ions. There are various parameters to be considered for 
usage of hydroxyapatite such as size, morphology, appropriate stoichiometry, phase 
composition and crystallinity. HAp is composed of strongly bonded, large crystal structures 
with smaller surface areas than the nano-sixzed, weakly bonded bone mineral crystals 
therefore reducing the rate of particle disintegration and crystal dissolution of the 
implant[12]. In particular, the high stability and flexibility of the apatite structure accounts 
for the great variety of possible cationic and anionic substitutions. Therefore, metal and ion 
substituted hydroxyapatite is very much used in bone tissue engineering applications 
nowadays.  
1.5.  Vascularization of bone grafts: 
For the engineered bone tissue to survive and integrate properly, vascularization is a requisite 
after implantation as it is necessary for the efficient oxygen and nutrition exchange between 
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the tissue. One of the drawbacks in implantation is that the molecular diffusion of oxygen and 
nutrients is limited over a short range of 150 – 200 µm and diffusional transport more than 
that distance results in acellular regions. Even though cell survival can be enhanced by using 
larger scaffolds, vascularization of the implant need to be considered for the successful 
implantation of the bone construct[13]. 
1.6.  Present strategies for improving vascularization in bone tissue constructs: 
Vascularization in bone tissue engineering is of utmost importance for the proper supply of 
oxygen, nutrients and growth factors thereby enhancing the new bone formation. To date, 
many strategies have been administered for the improvement of vascularization in bone tissue 
constructs. They are: i) growth factor delivery ii) co-culturing systems iii) gene delivery iv) 
development of microfluidic based network inside the scaffold v) using biomaterials with 
appropriate properties.  
1.6.1. Growth factor delivery: 
Cells communicate with each other via a cascade of signalling molecules (growth factors and 
proteins) to mediate cellular functions and also migration, proliferation and differentiation of 
cells. Some of the growth factors involved in the bone formation are: VEGF (vascular 
endothelial growth factor), FGF (fibroblast growth factor), PDGF (platelet derived growth 
factor), IGF (insulin-like growth factor), ET-1 (endothelin-1), ET-2 (endothelin-2), BMP-2 
(bone morphogenetic protein-2), BMP-7 (bone morphogenetic protein-7), TGF-β 
(transforming growth factor-β). In the bone micro environment, there is always a cross talk 
between the bone cells and the endothelial cells present in the surrounding blood vessels. For 
instance, VEGF produced by osteoblasts help in promoting angiogenesis in endothelial cells 
and BMP’s released by the endothelial cells help in osteogenic differentiation. Numerous 
researchers around the world working in the field of bone tissue engineering have tried to 
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incorporate the idea of delivering exogenous growth factors to control the cellular behaviour 
both in vitro and in vivo. But there are many disadvantages. Firstly, delivery of single growth 
factor alone cannot elicit a complete regeneration of bone. Secondly, this approach leads to 
the nonlocalized delivery of growth factors and transient cellular responses. Finally growth 
factor delivery is time and dose dependent[14]. 
1.6.2. Culturing Endothelial cells inside the scaffold: 
Another novel approach is to introduce endothelial cells or its progenitors directly into the 
scaffold. But this method has its drawback as there is only one cell type used and it is 
difficult to develop a complete vascularized tissue as the growth factors and signals from 
other cell types (in this case, bone cells) won’t be present. Also, it is an essential from which 
source the endothelial cells are taken as its angiogenic nature depends on the source[15] 
1.6.3. Co-culturing system: 
By now it is understood that both angiogenesis and osteogenesis plays a role in the bone 
formation in vivo. Angiogenesis is one of the requisites for the osteogenic differentiation as it 
helps in the migration of osteoblast precursor cells to the site of bone formation. Zhou et al., 
and Villers et al., in their research found that co-culturing of human mesenchymal stem cells 
(MSCs) and endothelial cells (ECs) within the biomaterial β-TCP resulted in the formation of 
vascularized bone tissue. Similarly, Wang et al., demonstrated that the co-culturing of human 
osteoblast-like cells and human umblical vein endothelial cells resulted in new bone 
formation with blood vessels. However, the co-culturing system becomes more complex to 
study and understand. Also research on co-culture system to date are very conflicting as in 
few studies though they showed the vessel formation there was no evidence for the integrity 
and functionality of the vessels within the grafts  (Fuchs et al., and Rouwkema et al.,)[15]. 
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1.6.4. Gene delivery: 
Limitations of gene delivery include: i) safety concerns for viral gene deliveries ii) non-viral 
delivery faces the problem of insufficient transport of pDNA into the nucleus and iii) lastly, 
many clinical trials of gene deliveries failed[16]. 
1.6.5. Development of microfluidic based network: 
Recent advancement in this field is the development of microfluidic based network for 
vascularization within the scaffold. These microfluidic channels mimic the micro 
vasculatures present surrounding the bone. Growing the endothelial cells within these 
microfluidic networks helped in developing the 3D vascular network within the scaffold. 
Even though this system is gaining much attention, it is very difficult to create such a 
complex array of system as it requires much sophisticated system and costly infrastructure 
and also it is very important to study the nature of the materials used for creating such 
channels[17]. 
1.7.  Development of pro-angiogenic biomaterial: 
Nowadays, development of pro-angiogneic biomaterial is gaining much attention as it 
triggers the cells to produce vast quantities of angiogenic factors in vivo which is normally 
achieved  by creating tissue hypoxic condition in vivo. It is already a known fact that hypoxia 
(decreased oxygen level) is one of the potent inducers of angiogenesis. Here, hypoxia 
inducible factor – 1α (HIF-1α) is the key regulator of angiogenesis. HIF-1 consists of two 
subunits: HIF-1β and HIF-1α. HIF-1β (also called aryl hydrocarbon receptor nuclear 
translocator (ARNT)) is constantly expressed  and present within the nucleus. On the other 
hand, HIF-1α is present in the cytosolic region, and it is oxygen sensitive. Under the 
normoxic condition, HIF-1α undergoes prolyl hydroxylation by the enzyme prolyl 
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hydroxylase (PHD) (which becomes active when its co-factors iron, 2-oxoglutarate and 
oxygen gets bound to it). Von-Hippel-Lindau protein (E3 ubiquitin ligase) then initiates its 
proteosomal degradation. But under hypoxic condition, since prolyl hydroxylase cannot be 
activated, accumulation of HIF-1α happens which moves into the nucleus and forms dimer 
with HIF-1β subunit which forms a complex with co-activator p-300 and trans activates the 
HIF-1 responsive genes by binding to the hypoxia responsive elements (HRE) region in those 
genes. One such gene is VEGF, which in turn activates the VEGF protein (a potent mitogen) 
that helps in the migration and proliferation of endothelial cells forming tubular structures. 
Also, it is known that in the bone remodelling compartment, expression of VEGF helps in 
osteoblast and osteoclast differentiation thereby enhancing the bone resorption and bone 
formation[18]. It is quite evident from the previous researches that even under normoxia, 
metal ions like nickel, cobalt, and copper inactivates the PHD enzyme by replacing iron (a 
co-factor required for the activation of PHD) which thereby stabilizes HIF-1α. Wu et al., 
exploited these strategies and showed that copper and cobalt doped mesoporous bioactive 
glass scaffolds can effectively induce cellular VEGF production and angiogenesis[19, 20]. 
But the stabilization of HIF-1α and subsequent activation of VEGF was very strong in the 
case of nickel ions. Therefore, we hypothesize to incorporate nickel in a biomaterial to 
exploit this area. However, high concentration of nickel may induce nickel toxicity. So a 
controlled ion release system is very much essential for vascularized bone tissue engineering 
strategy.    
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2.1. Objectives: 
To prepare and physicochemically characterize nickel doped nano hydroxyapatite. Further 
biologically characterize the prepared nickel doped nano hydroxyapatite to evaluate the 
osteogenic and angiogenic property of the material invitro.  
2.2. Work Plan: 
 
2.3. Rationale: 
As the scope of bone tissue engineering is rising in most parts of the world, the need 
for vascularization of the bone grafts is of paramount importance for successful implantation. 
Although there are many pre-vascularization techniques available, they come with their 
limitations. Hence this study is aimed at developing a pre-angiogenic nickel doped nano 
hydroxyapatite for bone tissue engineering application.  
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CHAPTER 3 
MATERIALS AND METHODS 
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3.1. Materials: 
Calcium nitrate tetrahydrate (Ca(NO3)2.4H2O), diammonium hydrogen phosphate 
((NH4)2HPO4), nickel nitrate hexahydrate (Ni(NO3)2.6H2O), cetyltrimethylammonium 
bromide (CTAB) and ammonia solution (25%) were purchased from Merck, India. 
Dulbecco’s Modified Essential Media (DMEM), Dulbecco’s Phosphate Buffer Saline 
(DPBS) solution, Trypsin-EDTA solution, Fetal Bovine Serum, antibiotic-antimycotic 
solution, and MTT assay kit were purchased from Himedia, India. Human VEGF ELISA kit 
was purchased from Abcam, UK. mRNA isolation kit (RNeasy Mini) and cDNA synthesis kit 
(MuLV Reverse Transcriptase Plus Kit) were bought from Qiagen and BioBharti 
LifeSciences Pvt. Ltd., India, respectively. The MG-63 cell line was procured from NCCS, 
India. 
3.2. Synthesis of nano-hydroxyapatite and nickel doped nano-hydroxyapatite: 
The well-known wet chemical precipitation method was employed here to synthesis 
the hydroxyapatite[21]. In this method, 200 ml of 0.05M Calcium nitrate tetrahydrate was 
taken in a beaker and placed in a sonicator bath at 80°C and the pH of the system was 
maintained at 10-12 by addition of ammonium hydroxide. To this solution, 200ml of solution 
containing 0.03M diammonium hydrogen phosphate and cetyltrimethylammonium bromide 
(CTAB) in the ratio 1:1 was added drop-wise at a constant flow rate of approximately 
1.5ml/min from a burette. The slurry was allowed to age for 24 hours and then repeated 
washing was done by centrifuging at 6000 RPM for 10 minutes to remove the ammonia 
byproducts and unwanted CTAB. The precipitate was then dried at 55°C for 24 hours to get 
the HAP powders. Nickel doped nano-hydroxyapatite samples were prepared using the above 
method in which different doping percentage of Nickel(II) nitrate hexahydrate(1%, 5%, and 
10%) was first added to the calcium nitrate solution and then reaction was started. The molar 
ratio of Ca/P in all the cases were maintained at 1.67.  
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3.3. XRD and FT-IR: 
The phase content of the samples was studied using XRD method. Philips XRD-
PW1700, Rockville USA instrument was used for this analysis. The scanning was done over 
a range of 2θ = 20°-60° at a scanning rate of 2° per minute[22].  
FTIR analysis was done to determine the functional groups present in the HAP 
Samples. It was performed using an AKTR FTIR Spectrophotometer instrument with the 
scanning range of 400 cm-1-4000cm-1, and the pellets were obtained using the KBr pelleting 
technique[23]. 
3.4. TEM and EDAX: 
JOEL JEM 2100 High –Resolution Transmission Electron Microscope (HR-TEM) 
was used to determine the nature of the synthesized HAP particles. Sample specimen were 
prepare using Copper grid with Formware –C Coating[24]. 
EDAX analysis was performed to determine the amount of nickel doped onto each 
sample[25]. 
3.5. BET and Zeta Potential Analysis: 
BET surface area analyser (Quantachrome Instruments) was used to determine the 
surface area, pore size and pore volume of the synthesized HAP particles the analysis was 
done at 5-point fast scan[26]. 
The ZETA potential of the HAP samples was determined using Marvelin DLS and 
ZETA analyser using water as the dispersion medium. The samples were dispersed in10 ml 
of water taken in a test tube and sonicated for 10 -15 min so that there wont be any 
agglomeration of HAP particles[27]. 
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3.6. Protein Adsorption Study: 
The adsorption of proteins by the samples can be studied by comparing it with the 
adsorption of BSA (Bovine Serum Albumin) by the samples. The residual protein 
concentration in the supernatant was determined using Bradford assay. The adsorption of the 
proteins by the samples were determined by subtracting the residual protein concentration 
from total protein concentration[28].   
3.7. Cytocompatibility Study: 
Cell proliferation of the samples were studied using MTT Assay on MG-63 cell line 
(from NCCS, Pune, India). 1 x 104 cells/well were added in 96 well plate and incubated for 
24 hrs for the cells to adhere properly. After 24 hours of incubation, the cells were treated 
with HAP samples at a concentration of 100µg/ml and then again incubated. After 1st, 3rd and 
5thday, MTT assay was performed[29].  
Cell cycle analysis was performed used FACS. 1 X 106 cells were seeded into 6 well 
plate and then treated with the samples at a concentration of 100µg/ml and then incubated. 
After 24 hours of sample treatment, the cells were trypsinized, washed with ice cold PBS and 
then fixed with 70% ice cold ethanol. After 24 hours, fixed cells were centrifuged at 
3000RPM and the pellets were suspended in 100µl of PBS and 500µl of PI staining dye and 
then allowed to stain for 30 min at room temperature[]. The samples were then analyzed 
using FACS Accuri C6 (BD Biosciences)[30]. 
Live/Dead assay was perfoemed using FACS for cell viability study. 5 X 105 MG-63 
cells were seeded onto the 6 well plate and left for adhereing at 37°C, 5% CO2 and 95% 
humidity. After 12 hours of incubation, the cells were treated with 100µg/ml of sample and 
further incubated. After one day of sample addition, the cells were trypsinized (also the 
supernatant was taken) and washed with ice cold PBS and then suspended in 500µl of PI 
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buffer (50µg/ml PI and 100 U/ml RNase) and incubated for 30 min at room temperature[31]. 
The samples were analysed using FACS Accuri C6 (BD Biosciences). The same protocol was 
followed to determine the amount of live cells on day 3 and day 5.   
3.8. FESEM study 
Field Emission Scanning Electron Microscopy (TOEL India TSM 6480 LV) was used to 
determine the effect of the samples on MG-63 cells. 5 X 104 cells were seeded onto the glass 
slides kept inside each well of the 12 well plate and left to adhere for 12 hours in the 
incubator at 37°C, 5% CO2. Thereafter, the cells were treated with the samples at a 
concentration of 100µg/ml and incubated at 37°C, 5% CO2. After 3 days of sample treatment, 
the cells were taken out and washed with SEM buffer at pH 7.2 (3 X 5min) and fixed with 
SEM grade gluteraldehyde for 2 hours. After 2 hours, the cells were again washed and fixed 
with osmium tetroxide for 2 hours. The cells were then washed and serially dehydrated with 
ethanol from 30% -100 % each (10 min) and then allowed to dry[32]. 
3.9. Expression of Runx2 and HIF-1α 
Expression of the differentiation marker Runx2 and angiogenic promoter HIF-1α was studied 
using immunocytochemistry analysis.5 X 104 MG-63 cells were seeded and incubated at 
37°C, 5% CO2 and 95% humidity for the cells to adhere properly. After the incubation 
period, the standard ICC protocol was followed. The cells were fixed with 4% 
paraformaldehyde (10 min, room temperature), permeabilized with permeabilization buffer 
(PBS with 0.25% TritonX) for 10 min at room temperature and then incubated with blocking 
buffer (1% BSA in PBST + 0.3M Glycine) for 30 min at room temperature to block any 
unspecific binding of the antibodies. After this, the cells were incubated for 1 hour at room 
temperature with the primary antibody which was followed by washing with PBS (3 X 5min) 
then incubated with secondary antibody tagged with Alexa Flour 488 (1:1000 dilution) for 1 
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hour at room temperature. Further, the cells were washed again with PBS (3 X 5min), stained 
with TRITC (tetramethylrhodamineisothiocyanate) phalloidin and Hoechst dyes to view 
under confocal microscope (TCS-SP8, Leica, Germany)[33]. 
3.10. VEGF Expression Study: 
Expression of VEGF was determined using human VEGF ELISA kit (Abcam 100662). For 
this purpose, 2 X 105 MG-63 cells were seeded onto a 12 well plate and incubated at 37°C, 
5% CO2 and 95% humidity for the cells to adhere properly. After 12 hours of incubation, the 
cells were treated with 100µg/ml of samples. After 48 hours of sample treatment, the 
supernatant was transferred to a sterile vial and then ELISA was performed as mentioned in 
the protocol from the kit. To summarize the process, 100µl of the samples were added to the 
8-well ELISA plate which were pre-coated with VEGF capture antibody and incubated for 
2.5 hours which was followed by washing, incubation with 100µl of 1X biotinylated VEGF 
detection antibody for 1 hour, subsequent washing and then incubation with 100µl of 1X 
HRP Streptavidin solution for 45min at room temperature. Further, it was incubated with 
100µl of TMB onestep substrate reagent for 30 min at room temperature for the colour 
development. Subsequently stop solution was added, and the absorbance was measured at 
450nm[33].      
3.16. RT-PCR analysis: 
Expression of VEGF, Runx2, HIF-1α was checked using RT-PCR. For this purpose 1 x 106 
cells were seeded on to each well of a 6-well plate and cultured following the protocol 
mentioned above. After 24 h of incubation, samples (100µg/ml) were added to the  cells, and  
it was further incubated for 48 h. After incubations, cells were lysed using lysis buffer. 
Extraction of mRNA from the cell lysate was done using RNA isolation kit (QIAGEN 
RNeasy Mini Kit) following the manual provided by the supplier. At the end of the process, 
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the concentration of mRNA was estimated spectrophotometrically (Nanodrop)  and 
appropriate dilution was made to keep the mRNA concentration same for all the samples. 
Then mRNA were converted to cDNA  and subjected to PCR using BioBharti MuLV 
ReverseTranscriptase Plus Kit.  For PCR, cDNA were mixed with primers (listed below) and 
'PCR mix’ following appropriate stoichiometry as per the instruction given in the manual. 
After completion of the PCR, sample were analyzed using 1.5 %  agarose gel[34]. 
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RESULTS AND DISCUSSION 
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4.1. Preparation of Ni+2 doped nano hydroxyapatite 
Synthesis of nano hydroxy apatite and Ni+2 doped nano hydroxy apatite was done by 
ammoniacal precipitation method (Table.1 and Fig.1). To control the size of the nanoparticle, 
a cationic surfactant CTAB was used as a capping agent [35]. Three different Ni+2 doped 
nano hydroxy apatite samples were prepared by varying the doping concentration. The yield 
of nano HAp powder was between ~ 0.9 to 1.0 g in all the cases.  To break the agglomerate 
of the synthesized nano hydroxy apatite, the dried samples were ball- milled. Physical 
inspection of the powder revealed that all powders were free flowing. Pure nano hydroxy 
apatite was white coloured, but the colour changed from white to whitish- green with Ni 
doping because of hexaaquanickel ion[36]. ) and Yan Li et al., (2010) when they doped Co+2 
and Cu+2, respectively in hydroxyapatite [25, 37]. 
Table 1.  Composition, yield and physical appearance of nHAp and Ni+2 doped nHAp  
S.No Samples Composition 
 
[Ca(NO3)2 .4H2O 
+ 
Ni(NO3)2.6H2O] 
g/200ml 
(NH4)2HPO4 
g/200ml 
 
Yield 
(g) 
Colour 
1. HAP Hydroxyapatite 
[Ca/P: 1.67] 
2.36  + 0.0 
 
0.79 
 
1.00±0.03 
 
Milk 
White 
2. N1-HAP Hydroxyapatite + 
1%(w/w)Nickel 
[(Ca+Ni)/P: 1.67] 
2.36 + 0.0236 
 
0.796 
 
0.97±0.01 Creamy 
White 
3. N5-HAP Hydroxyapatite + 
5%(w/w)Nickel 
[(Ca+Ni)/P: 1.67] 
2.36 + 0.118 
 
0.822 
 
0.99±0.09 Greenish 
White 
4. N10-HAP Hydroxyapatite + 
10%(w/w)Nickel 
[(Ca+Ni)/P: 1.67] 
2.36 + 0.236 
 
0.854 
 
1.00±0.01 
 
Greenish 
White 
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Fig. 1 nHAp and Ni+2 doped nHAp prepared using ammoniacal precipitation method. 
 
4.2. EDAX  
The extent of doping is a major concern for the metal doped bio ceramics, especially for 
metal ion doped hydroxyapatite. So far, many research groups have reported the synthesis of 
different metal ions (example cobalt, magnesium, zinc, iron) doped hydroxyapatite. A critical 
analysis of their results revealed that in most of the cases actual doping was less than the 
expected value (theoretical percentage doping). In the present study, the presence of dopant 
and extent of doping was confirmed by EDAX. The result showed that ammoniacal 
precipitation method can be successfully used for the doping of nickel in hydroxyapatite. It 
was observed that though there was a gradual increase in percentage doping with an increase 
of Ni+2 concentration in the precursor, however, the actual doping was less in comparison to 
the theoretical value (Fig.2). Analysis showed that in all cases the actual loading was less 
than 30% of the theoretical doping. In recent reports Guerra Lopez et.al, has shown that 
percentage doping for transition metals including nickel generally less than 1/3rd of the 
theoretical doping. This happens probably because of the formation of stable amine co-
ordination complex of Ni+2 at basic pH. That complex ions are generally much bigger in size, 
therefore, failed to get accommodated in the crystal lattice of hydroxyapatite[38]  
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4.3. TEM  
The size of the hydroxyapatite nano crystal is very important for bone tissue application. In 
vivo, the nano hydroxyapatite is synthesized in situ during bone remodelling inside the grove 
of the collagen helices. The native size of hydroxyapatite nanocrystals lies between (2nm- 
10nm)[39].Here, TEM micrographs showed that the size of the synthesized doped HAp 
particles were all in nano range with an average diameter of15-17nm 
approximately(Fig.2).All the nanoparticles were found elliptical. The average ferret diameter 
for HAP was 17.2 ± 3.9 nm while the same for N1-HAP, N5-HAP and N10-HAP was 15.6 ± 
3.3, 16.8± 3.0 and 15.1 ± 3.0 nm, respectively. Such a close value of the average ferret 
diameter of all the doped samples clearly implies that the doping of nickel has no significant 
impact on the size of the nano crystals.  
 
Fig. 2. [A] FESEM micrographs of nHAp and Ni+2 doped nHAp. [B] TEM Images of nHAp and Ni+2 
doped nHAp. [C] Nano particle size distribution. TEM Image based analysis was done using NIH-ImageJ 
software. For each analysis, 25 individual particles were considered (p< 0.05). [D] Percentage of Ni+2 
doping with respect to calcium content (w/w). Results were expressed as Mean ± S.D of three independent 
experiments (p <0.05).   
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4.4. XRD 
Analysis of the XRD profiles (Fig.3) of the doped HAp showed that there were no additional 
peaks corresponding to nickel.  The characteristic peaks of HAp corresponding to 32°, 33° 
and 34° 2θ (for planes (211), (300) and (302) respectively) were found in all samples. 
Analysis of the crystal structure of the samples (Table.2) showed that the magnitude of the 
lattice parameter 'c' for HAP, N1-HAP and N5-HAP and N10-HAP were almost same. 
Further analysis showed that there was a decrease in crystallinity with an increase in doping 
percentage.  In this present study, no such peak broadening was observed which implies that 
Ni+2 doping did not distort the apatite crystal much. However, the variation in crystal 
parameter observed was probably because of the smaller ionic radii of Ni+2 (0.72Å) in 
comparison to Ca+2 (0.99Å).   
Table 2.  Crystal parameters of nHAp and Ni+2 doped nHAp. Percentage crystallinity and d spacing were 
calculated using the XRD and TEM diffraction data corresponding to 002 planes. For the analysis of 
crystal lattice parameters, ‘an’ and ‘c’, 300 and 002 planes are considered.  
S.No Samples % Crystallinity Crystal lattice 
parameters 
‘d’-spacing 
(nm) 
‘a.' ‘c’ 
1. HAP 42 9.37 6.88 0.3644 
2. N1-HAP 42 9.43 6.90 0.3642 
3. N5-HAP 64 9.37 6.88 0.3624 
4. N10-HAP 22 9.43 6.90 0.3578 
 
4.5. FT-IR      
The FTIR analysis of the samples revealed the characteristic peaks of hydroxyapatite (Fig.3) 
No major peak shift was observed in the nickel doped samples. The peaks at 630cm-1, 600cm-
1 and 550cm-1 corresponding to free OH and υ4 vibrational bands of  a phosphate group 
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(PO4)
3- respectively appears less prominent as the doping increases and becomes merged with 
N10-HAP. Peaks for other bands like υ3 stretching of (PO4)3- (1100 - 1000 cm-1) and 
υ2bending of (PO4)3- (470cm-1) also became less prominent as the doping increases. These 
results were found to be in accordance with Guerra-López et al. and G. Gergely et al.[38]. 
This maybe because of the mild variation in that ionic environment in the crystal lattice 
which leads to alteration in the stretching field. All the samples show a common peak of H- 
bonded OH stretching at 3570cm-1. However in case of N5-HAP and N10-HAP, a new peak 
appeared at 3640cm-1 that could be attributed to the stretching of free OH, which becomes 
more intense with the increasing doping. Bands at 1470cm-1 and 870cm-1 corresponding to 
(CO3)
2- was seen due to the CO2 adsorption from the atmosphere. Adsorbed water gave two 
kinds of the band, O-H bending (1640cm-1) and O-H stretching (3450cm-1) which was also 
due to the hydroxyl group present in the apatite. The peak at 1640cm-1 became wider in N10-
HAP and N1-HAP, and this may be due to crystal deformation.  
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Fig. 3. [A] XRD analysis of nHAp and Ni+2 doped nHAp. Important characteristic peaks are marked in 
the figure, and its corresponding crystal planes were mention in the embedded table. [B] FT-IR analysis 
of nHAp and Ni+2 doped nHAp. Important characteristic peaks are marked in the figure, and its 
corresponding bond perturbation were mention in the embedded table. 
 
4.6. BET Surface Area Analysis: 
Large surface area is one of the key parameters why nanomaterials are highly reactive when 
compared micro or macro scale materials. For this reason, we analysed the surface area of the 
synthesized HAp samples. The surface area of pure HAP was found to be 109.120m2/g and 
was in accordance with the previously reported value[40]. The same for N1-HAP, N5-HAP, 
and N10-HAP were 107.591m2/g,111.732m2/g and 83.165m2/g respectively (Table 3). Our 
TEM study showed that the size of the nano particles for all samples were close. So it is 
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expected that the surface area of the nanomaterial should also be same unless there is a 
variation in the porosity of the synthesized materials. The BET study showed that there was 
no significance variation in surface area with doping which implies the doping has no 
significant effect on the porosity of the material. 
4.7. Zeta potential of HAP particles: 
The zeta potential of the nano materials influences the biological performance of the 
materials in a number of ways. It is already reported that in physiological condition, the zeta 
potential modulate protein adsorption, cell material interaction, and cellular uptake of the 
nano material. Doping of metal ions can change the normal zeta potential of hydroxyapatite 
by two ways: i) By altering the surface charge density ii) By imparting strain in the crystal 
that could lead to differential ion dissolution from a crystal. Here, the zeta potential of HAP 
was found to be -3.54mV and was found in accordance with former reports. It is also reported 
that the metal ion doping causes a variation in the zeta potentialin hydroxyapatite. However, 
the extent of such variation depends on the nature of the metal ion and extent of doping. 
Here, we have observed that with Ni+2 doping, the zeta becomes more positive in comparison 
to the HAP, and however there is no proportional increase in zeta with the increase in doping 
concentration (Table.3).  
 
 
4.8. Protein adsorption: 
The protein adsorption onto the implant plays a vital role in determining the host response 
towards the implant. There are number of plasma proteins (albumin, immunoglobins and 
fibrinogen, fibronectin) that interact with the biomaterial surface. Hence, BSA (Bovine 
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Serum Albumin) was used as a model protein to study the protein adsorption on the Ni doped 
hydroxyapatite. As reported earlier, protein adsorption by HAp depends on surface area and 
zeta potential more specifically on the charge distribution of the Ca/Ni and P ions over the 
crystal surface since Ca and P sites are the sites for the electrostatic adsorption of proteins 
[41]. Both HAp and doped Hap samples showed similar protein adsorption onto their surface 
(Table.3). The average protein adsorption was found in the range 900µg/10mg of the 
samples. The result clearly implied that the doping of nickel did not influence the protein 
adsorption capacity of hydroxyapatite nanoparticles.  
Table 3. Analysis of surface area, pore volume, zeta potential and protein absorption. 
The data were mean of three independent experiments and presented as Mean ± S.D. 
S.No Samples Surface area 
(m2/g) 
Pore volume 
(cc/g) 
Zeta potential 
(mV) 
Protein adsorption 
(mg) 
1. HAP 109.1 0.041 -3.5 881±19.5 
2. N1-HAP 107.6 0.040 -1.0 885±7.4 
3. N5-HAP 111.7 0.046 3.2 873±18.4 
4. N10-HAP 83.2 0.034 1.1 878.5±1.2 
 
4.9. MTT assay  
During development, osteoblast cells are the one which first proliferates, then differentiates 
into osteocytes and produce an extracellular bone matrix. It is now well established that 
osteoblast proliferation is essential for the bone regeneration and remodelling. In this present 
study, the MTT assay was performed for the cells treated with Ni doped HAp samples 
(Fig.4). Pure HAp showed the highest cell proliferation in comparison to all other samples.  
The extent of cell growth was very much similar for all the samples on day 1.  The 
Data protected for publication 
Please contact 
banerjeei@nitrkl.ac.in for details 
 
29 | P a g e  
 
proliferation rate becomes slow from day 3 with N10-HAp giving the least cell growth. N1-
HAP and N5-HAP showed similar proliferation rate as pure HAP on day 3 but on day 5 
proliferation reduced when compared to pure HAP. This behaviour may be attributed to 
either nickel doping being cytotoxic to cells, or the cells are getting differentiated after day 3.  
4.10. Cell cycle analysis 
Cell cycle analysis (Fig.4) showed that nickel doping did not perturb normal cell cycle 
progression. For all the treatment groups, distribution of cell populations in different phases 
of cell cycle was similar to that of control (TCP) which indicates that nickel doping has no 
detrimental effect on viability and cell proliferation.  For all the cases, highest cell population 
was observed in G0/G1 phase (between 55-65%) except the cells treated with N5- HAP where 
percentage cell population in G0/G1 was even little higher. More interestingly, N5- HAP has 
least cell population in S phase (12%). On the other hand, least population in G2/M phase was 
found in N10-HAP treated group.  In bone physiology, a high population of cells in G0/G1 
often indicates their commitment towards differentiation. Therefore, a higher value G0/G1 in 
case of N5-HAP treated group could be associated with differentiation potential of the 
material. FACS analysis also showed that the percentage cell population in pro G0/G1 (a 
phase associated with apoptosis) was negligible for all groups which imply that nickel doping 
has no adverse effect on the cell viability.  
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Fig. 4. [A] Study of cell proliferation by MTT assay. Data were expressed as Mean ± S.D (n=3). Statistical 
significance was checked for p< 0.005. [B] Study of the cell cycle after 24 h of treatment. Experiments 
were done in triplicate. Representative histograms for each sample was presented. 
  
4.11. Live/Dead Assay: 
It was evident from the literature that hydroxyapatite and doped hydroxyl apatite support 
osteoblast cell viability and proliferation in vitro for longer period. Our MTT analysis 
apparently showed Ni doped hydroxy apatite samples help in MG-63 cell proliferation. 
However, it is important to mention that, MTT assay is actually a measurement of the 
metabolic state of the cells and often fails to indicate cell proliferation effectively. Therefore, 
it was important to quantify the variation in a live population of cells. For this purpose, flow 
cytometry based Live / Dead assay was performed to determine the percentage of live cells in 
the total cell population after the treatment (Table.4). The result showed that the percentage 
of live cells in the total cell population for all the samples were more than 90%. This clearly 
suggests that Ni+2 doped hydroxyl apatite were as cytocompatible as control (synthetic 
hydroxyl apatite).Our MTT study showed that there was a decrease in cell proliferation rate 
with time. As mentioned earlier, the two possibilities could be either cell death or cell 
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differentiation. It was evident from the live dead assay that there was no significant cell death 
at the later phase of culture which clearly implied that the decrease in cell proliferation could 
be because of differentiation of cells in presence of doped nano hydroxy apatite. 
Table 4. Analysis of the percentage of live cells after sample treatment. The assay was performed by flow 
cytometry using PI as a probe. Data were expressed as Mean± S.D (n=3).   
 
Day 
Live Dead Assay: Percentage of live cells 
Control HAP N1-HAP N5-HAP N10-HAP 
Day1 94.95±1.23 94.95±1.01 
 
93.45±1.49 
 
92.76±1.48 
 
89.99±2.53 
Day3 94.20±0.91 
 
91.73±0.48 
 
93.37±1.09 
 
92.95±0.07 
 
94.54±1.10 
 
Day5 95.08±1.83 
 
92.07±1.48 
 
92.14±1.14 
 
91.13±0.87 
 
92.28±0.14 
 
 
4.12. Differentiation of osteoblasts 
Osteoblast differentiation into osteocytes and its maturation were the main processes 
involved in the effective bone remodelling after bone matrix deposition and osteoblast 
proliferation. The inorganic components of bone (hydroxyapatite), extra cellular matrix and 
its components along with many different kinds of growth factors like bone morphogenic 
proteins (BMPs, epidermal growth factors (EGFs) , fibroblast growth factors(FGFs), and 
many more widely affect the osteoblast differentiation[41]. Transcription factor runx2 is one 
among the signature protein which is a pre-requisite for the mesenchymal stem cells to 
differentiate to osteoblast cells. It is important to mention that MG -63 is a mature osteoblast. 
Therefore, Runx2 expression always remains in basal level in MG-63 in comparison to its 
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progenitor. A qualitative analysis of immuno-cytochemistry micrograph showed that as per 
expectation Runx2 is not localized on cell nucleus (as the cells has passed their early 
differentiation phase) and distributed all over the cells. Quantitative Image analysis using 
NIH-Image J showed that variation in expression level of Runx2 in all samples were 
statistically insignificant.  When checked at mRNA level by RT-PCR, it was observed that 
there was no sample specific variation in the expression of Runx2 (Fig.5).  These two 
experiments altogether showed that the presence of nickel doesn’t affect the expression of 
runx2.    
SEM micrograph taken after 3 days of sample treatment showed clear evidence of  bone 
matrix deposition  and nodule formation in all samples (Fig.5). Previously, Gough et.al 
outlined that the formation of the nodule is a signature of osteoblast differentiation. N5-HAP 
showed bigger nodule formation when compared to all samples which implied its greater 
osteogenic property.  
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Fig. 5. [A] SEM images of cells cultured in presence of nHAp and Ni+2doped nHAp samples at day 3. [B] 
Confocal micrographs of cells cultured in presence of nHAp and Ni+2doped nHAp samples at day 3. Red 
[F actin], Blue [DAPI] and Green [Runx2]. [C] Quantitative image analysis of Runx 2 expression. 
Intensity was calculated for 10 cells.  Statistical significance was checked for p< 0.005. [D] Study of Runx2 
expression by RT-PCR. 
 
4.13. Expression of VEGF 
The expression of VEGF measured by ELISA (Fig.6) showed that there were a 2.3 fold, 3.5 
fold and 3.8 fold increase in VEGF expression for N1-HAP, N5-Hap, N10-HAP treated 
group respectively, with respect to pure HAP after 48 h of treatment.   Statistical analysis 
revealed that such increase in cellular VEGF expression with the increase in doping 
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concentration is statistically significant (p<0.005) for any two samples including control.  
RT-PCR based analysis of VEGF expression at mRNA level (Fig.6) further confirmed the 
increase in VEGF  gene expression with the  increase in Ni+2 doping concentration. An image 
based analysis of the intensity of the PCR bands (amplicons) showed that, in comparison to 
pure HAp, maximum expression was obtained for N10-HAP ( fold )   followed by N5-HAP ( 
fold )   and N1-HAP ( fold )   respectively.  
4.14. Expression of HIF-1α  
In this study, the immunocytochemistry profile of HIF-1α showed that the nickel doped HAp 
samples had a significantly higher expression of HIF-1α. In case of bone formation during 
embryogenesis, vascularisation of cartilage analague is a key step for further bone formation. 
Mesenchymal condensation Generally, under normoxic conditions, prolyl hydroxylase 
enzyme activates the proteosomal degradation pathway of HIF-1α through ubiquitination. 
Bivalent metal ions such as nickel, cobalt, copper, etc. mimics hypoxia condition by 
replacing Fe2+ ions, the key cofactor of the prolyl hydroxylase enzyme and thereby 
inactivating the enzyme and stabilizing HIF-1α. Interestingly, in this study, we observed that 
such expression level of HIF-1α did not show a linear trend with respect to nickel doping 
concentration (Fig.6). Generally, the release of ions and the degradation of HAp depends on 
its crystal structure (Ref.). Hence, the variation among the crystal structure of doped HAp 
might lead to variation in the nickel release and further HIF-1α expression. In case of HIF-1α 
expression, N5 showed the highest expression followed by N10, N1 and HAP, respectively. 
But in case of VEGF expression, the increase was linear with respect to nickel doping 
concentration. This might be explained on the basis that VEGF expression does not merely 
depend on the HIF-1α expression level. Apart from this, Lee et al. (2012) stated that Runx2 
also stabilizes HIF-1α by competing with the Von Hippel-Lindau Protein (pVHL) (protein 
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that aids in proteosomal degradation of HIF-1α) and stabilizes HIF-1α protein.  From the 
Runx2 immunocytochemistry expression profile, N5 showed better expression of Runx2 
followed by N10.  It was also reported  for cu and co doped proangiogenic biomaterials 
VEGF expression  profile  not always follow the HIF-1α profile.  
 
Fig. 6. [A] Study of VEGF expression by MG-63 cells. Cells were treated with Ni+2 doped nHAp for 48 h. 
Data are expressed as Mean ± S.D.  [B] Study of  VEGF mRNA expression by RT-PCR. [C] Study of 
HIF-1α expression by MG-63 cells after 12 h post treatment by immuno-cytochemistry. Confocal 
micrographs of the cells [Red (F actin), Blue (DAPI) and Green (HIF-1α)]. [D] Quantitative image 
analysis of HIF-1α  expression. Intensity was calculated for 10 cells.  Statistical significance was checked 
for p< 0.005. [E] Study of HIF-1α mRNA expression by RT-PCR. 
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5. Conclusion:  
Here we have reported the synthesis and characterization of Ni+2 doped nHAp and evaluation 
of its osteoconductive and proangiogenic properties. Bivalent nickel has been known as an 
inducer of cellular VEGF. We hypothesized that incorporation of Ni+2 into osteoconductive 
nHAp might convert it into a proangiogenic-osteogenic biomaterial. Our study showed that 
Ni+2 doped nHAp particles of the narrow size distribution could effectively be prepared by 
wet chemical precipitation method using CTAB. Doping of Ni+2 upto 3.3 % w/w of Ca+2 did 
not cause crystal deformation. Similarly, physical properties like surface area, zeta potential 
and protein absorption remained almost same with Ni+2 doping. All the doped samples were 
bone cell compatible and osteoconductive. Analysis showed that Ni+2 doped nHAp samples 
were a potent inducer of cellular VEGF, and the expression of VEGF was directly 
proportional to the doping concentration of Ni+2. A mechanistic analysis further implied the 
involvement of Ni+2 in HIF-1α stabilization followed by increased VEGF expression.  
Comparison of these results with the relevant literature revealed number of important points. 
Firstly, although biological performance of the Ni+2 doped nHAp was similar to the other 
proangiogenic bio-ceramics (metal ion doped), i.e. all are osteoconductive as well as potent 
VEGF inducer, the relative VEGF expression per unit quantity of doping was higher in the 
present case. Secondly, the extent of nickel doping was less than all the reported values and 
below the toxic level. Finally, particle size was found within the range of 14-19 nm, which is 
good for bone tissue engineering. In conclusion, Ni+2 doped nHAp is a proangiogenic–
osteogenic material and could be used in bone tissue engineering. The response of endothelial 
cells (viability and tube formation) against these materials in vitro has to be studied. 
Moreover, it is important to assess the biological performance of the materials in vivo. 
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